ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Don't Just Swap The Engine. Redesign The Factory.

  Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.

• Enhancing Oncology Trials With Clinical Platform Solutions

  This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.

• Running Your Trial In Your eTMF

  Discover how people are part of the electronic Trial Master File trifecta and what to consider when implementing an eTMF in clinical studies.

• Webinar Recap: How EDC Can Support Modern Clinical Trials

  Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.

• 5 Features to Look for in Your Next eTMF

  Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.

• Defining 'Evidence Generation' Within Modern Clinical Trials

  Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• Re-Consent In Clinical Trials: Streamlining With eConsent

  Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.

• Achieving Faster, Simpler Validation Through Crowdsource UAT

  An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.